CA2098773A1 - Recombinant Coccidia and Its Use in a Vaccine - Google Patents
Recombinant Coccidia and Its Use in a VaccineInfo
- Publication number
- CA2098773A1 CA2098773A1 CA2098773A CA2098773A CA2098773A1 CA 2098773 A1 CA2098773 A1 CA 2098773A1 CA 2098773 A CA2098773 A CA 2098773A CA 2098773 A CA2098773 A CA 2098773A CA 2098773 A1 CA2098773 A1 CA 2098773A1
- Authority
- CA
- Canada
- Prior art keywords
- coccidia
- recombinant
- species
- vaccine
- strains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000224483 Coccidia Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000894007 species Species 0.000 abstract 4
- 230000001717 pathogenic effect Effects 0.000 abstract 2
- 208000003495 Coccidiosis Diseases 0.000 abstract 1
- 206010023076 Isosporiasis Diseases 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 238000011081 inoculation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention provides for recombinant coccidia comprising a relatively non-pathogenic strain of coccidia to which has been introduced DNA from one or more other strains or species of coccidia. In an aspect of the invention, there is provided a recombinant coccidiosis vaccine comprising a relatively non-pathogenic strain of coccidia to which has been introduced sufficient DNA of one or more other strains or species of coccidia to produce immunity to the multiple species in a host through inoculation of the host by the recombinant species.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002098773A CA2098773C (en) | 1993-06-18 | 1993-06-18 | Recombinant coccidia and its use in a vaccine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002098773A CA2098773C (en) | 1993-06-18 | 1993-06-18 | Recombinant coccidia and its use in a vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2098773A1 true CA2098773A1 (en) | 1994-12-19 |
CA2098773C CA2098773C (en) | 1999-09-21 |
Family
ID=4151815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002098773A Expired - Lifetime CA2098773C (en) | 1993-06-18 | 1993-06-18 | Recombinant coccidia and its use in a vaccine |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2098773C (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999008704A1 (en) * | 1997-08-20 | 1999-02-25 | Lee Eng Hong | Method of protecting against chronic infections |
US6495146B1 (en) | 1995-06-07 | 2002-12-17 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
US6500438B2 (en) | 1995-06-07 | 2002-12-31 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
US6984378B1 (en) | 1999-02-26 | 2006-01-10 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
US7166290B2 (en) | 2001-08-30 | 2007-01-23 | Embrex, Inc. | Methods for producing oocysts |
US11000580B2 (en) | 2010-12-27 | 2021-05-11 | Eng Hong Lee | Roadmap for controlling malaria |
-
1993
- 1993-06-18 CA CA002098773A patent/CA2098773C/en not_active Expired - Lifetime
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495146B1 (en) | 1995-06-07 | 2002-12-17 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
US6500438B2 (en) | 1995-06-07 | 2002-12-31 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
US7018640B2 (en) | 1995-06-07 | 2006-03-28 | Pfizer Incorporated | In ovo vaccination against coccidiosis |
WO1999008704A1 (en) * | 1997-08-20 | 1999-02-25 | Lee Eng Hong | Method of protecting against chronic infections |
US6306385B1 (en) | 1997-08-20 | 2001-10-23 | Eng-Hong Lee | Method of protecting against chronic infections |
US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
US6984378B1 (en) | 1999-02-26 | 2006-01-10 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
US7229615B2 (en) | 1999-02-26 | 2007-06-12 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
US7166290B2 (en) | 2001-08-30 | 2007-01-23 | Embrex, Inc. | Methods for producing oocysts |
US9107865B2 (en) | 2001-08-30 | 2015-08-18 | Zoetis Services Llc | Methods for producing oocysts |
US11000580B2 (en) | 2010-12-27 | 2021-05-11 | Eng Hong Lee | Roadmap for controlling malaria |
Also Published As
Publication number | Publication date |
---|---|
CA2098773C (en) | 1999-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG102784A (en) | Synthetic hiv genes | |
CA2011878A1 (en) | Immunogenic regions on the e7 protein of human papillomavirus type 16 | |
AU7154394A (en) | Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics | |
PL335050A1 (en) | Synthetic genes gag hiv | |
WO1995006732A3 (en) | Bacterial exported proteins and acellular vaccines based thereon | |
CA2195935A1 (en) | Streptococcus equi vaccine | |
AU3904685A (en) | Cloning of dna for protozoal antigens | |
BG105838A (en) | A container having pressure responsive panels | |
CA2165954A1 (en) | Prostaglandin receptor fp and dna encoding it | |
CA2098773A1 (en) | Recombinant Coccidia and Its Use in a Vaccine | |
AU1463097A (en) | Helicobacter pylori bacterioferritin | |
AU7161994A (en) | nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics | |
NZ332912A (en) | rinseable hard surface cleaner containing a silicate, a hydrophobic acrylic polymer and a surfactant | |
WO1999004011A3 (en) | Hiv-1 group o antigens and uses thereof | |
EP1666057A3 (en) | An acellular vaccine comprising Bordetella pertussis antigens | |
WO1994016079A3 (en) | Novel bacillus thuringiensis toxins active against corn rootworm larvae | |
CA2245545A1 (en) | Vaccines against varicella zoster virus gene 63 product | |
AU2833789A (en) | Non-reverting rna viruses | |
EP0806476A3 (en) | Attenuated strains of leishmania and uses thereof | |
WO1995005460A3 (en) | Feline immunodeficiency virus isolate ncsu 1 | |
CA2084384A1 (en) | Dna coding for uricase and process for producing uricase | |
AU1099697A (en) | Novel xylanases, genes encoding them, and uses thereof | |
AU8867198A (en) | (mycobacterium) strain with modified (erp) gene and vaccine composition containing same | |
AU4815497A (en) | Biocontrol of fungal soilborne pathogens by (pythium oligandrum) | |
AU8132994A (en) | Nucleic acids encoding {his5, trp7, tyr8}-gnrh preprohormone and {ser8}-gnrh preprohormone and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |